Latest Advances

  • Condition: Organizing Pneumonia (OP) in Rheumatoid Arthritis (RA)
  • Journal: BMJ case reports
  • Treatment Used: Corticosteroid Therapy
  • Number of Patients: 2
  • Published —
This case report describes patients with rheumatoid arthritis (RA) who developed organizing pneumonia (OP) after initiation of methotrexate (MTX) treated with corticosteroid therapy.
  • Condition: Interstitial Lung Disease (ILD) Associated with Rheumatoid Arthritis (RA)
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Abatacept
  • Number of Patients: 263
  • Published —
This study assessed the effectiveness of abatacept (ABA) in patients with rheumatic arthritis (RA) with interstitial lung disease (ILD).
  • Condition: Rheumatic and Musculoskeletal Disease, SARS-CoV-2
  • Journal: Rheumatology international
  • Treatment Used: Rituximab
  • Number of Patients: 13
  • Published —
This study assessed the characteristics and outcomes of rheumatic and musculoskeletal disease (RMD) patients who were treated with rituximab and had suspected or confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
  • Condition: COVID-19
  • Journal: The Journal of clinical investigation
  • Treatment Used: Baricitinib
  • Number of Patients: 20
  • Published —
This study tested the safety and efficacy of using baricitinib to treat patients with COVID-19 infections.
  • Condition: Rheumatoid Arthritis
  • Journal: The Lancet Rheumatology
  • Treatment Used: Hydroxychloroquine Alone and in Combination with Azithromycin
  • Number of Patients: 0
  • Published —
This study evaluated the safety of hydroxychloroquine, alone and in combination with azithromycin, to determine the risk associated with its use in routine care in patients with rheumatoid arthritis.
  • Condition: COVID-19 and Rheumatoid Arthritis (RA)
  • Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • Treatment Used: Tocilizumab
  • Number of Patients: 120
  • Published —
This study investigated the effects of tocilizumab on a determinant of vascular permeability and myocardial function patients with in rheumatoid arthritis (RA).
  • Condition: Rheumatoid Arthritis or COVID-19
  • Journal: Cells
  • Treatment Used: Small Molecule Inhibitors
  • Number of Patients: 0
  • Published —
The study researched the use of small molecule inhibitors for patients with rheumatoid arthritis.
  • Condition: Coronavirus Disease 2019 (COVID-19) in Autoimmune and Inflammatory Conditions
  • Journal: Rheumatology international
  • Treatment Used: Immunosuppressive Therapies
  • Number of Patients: 62
  • Published —
This study described the characteristics of patients with rheumatic and musculoskeletal diseases (RMDs) and immunosuppressive therapies with Coronavirus disease 2019 (COVID-19).
  • Condition: Children with Rheumatic Diseases During COVID-19 Pandemic
  • Journal: Rheumatology international
  • Treatment Used: Immunosuppressive Treatment
  • Number of Patients: 853
  • Published —
This study sought determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease 2019 (COVID-19) poses a risk for children with rheumatic diseases on immunosuppressive treatment.
Showing 1-12 of 39